Eosinophilic fasciitis in a female child

Ortega‐Loayza, Alex G.; Merritt, Bradley G; Groben, Pamela A.; Morrell, Dean S.

doi:10.1016/j.jaad.2007.05.014

Cited by 23 publications

(10 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Clinical improvement was observed in a short period of combination therapy with corticosteroid and methotrexate. There are several studies reporting clinical improvement with corticosteroid and methotrexate combination therapy, similar to the situation in our case (16,17). In 93 cases we evaluated from the literature, the treatment consisted mostly of prednisolone (46.2%) and prednisolone-methotrexate combination therapies (10.8%).…”

Section: Discussionsupporting

confidence: 69%

Eosinophilic Fasciitis: A Case Report and Review of the Literature

et al. 2010

View full text Add to dashboard Cite

ÖzetEozinofilik fasiit, periferik eozinofili, fasiit ve "Groove" işareti ile karakterize nadir görülen bir durumdur. Periferal kanda eozinofili ve özellikle ekstremitelerde skleroderma benzeri deri endurasyonları bu hastalığın karakteristik özellikleridir. Sistemik organlar genellikle etkilenmemiştir. Bu yazıda, uzun süre tanı konamayan ve kas biyopsisi sonrası eozinofilik fasit tanısı koyduğumuz 35 yaşındaki erkek olgunun klinik özellikleri ve hastalık hakkında yaptığımız literatür taramasının sonuçları sunulmuştur. (Turk J Rheumatol 2010; 25: 208-13 Abst ractEosinophilic fasciitis is a rare entity characterized by peripheral eosinophilia, fasciitis and "groove sign". The characteristic features of this inflammatory disease include scleroderma-like skin indurations, predominantly on the extremities, and peripheral blood eosinophilia. Systemic organs are generally not affected. In this paper, we present the clinical characteristics of a 35-year-old male patient who could not be diagnosed for a long period and was diagnosed as eosinophilic fasciitis following muscle biopsy. We also include herein the results of our literature survey regarding this disease. (Turk J Rheumatol 2010; 25: 208-13)

show abstract

Section: Discussionsupporting

confidence: 69%

Eosinophilic Fasciitis: A Case Report and Review of the Literature

et al. 2010

View full text Add to dashboard Cite

show abstract

“…29 Methotrexate has been used in juvenile EF in combination with low dose corticosteroids and a clinical response was documented. 9,12 It is of note that methotrexate led to a clinical improvement when it was used for the treatment of persistent, progressive, or relapsing disease when steroids alone were not sufficient. 30,31 Increased histamine levels have been documented in some patients with EF.…”

Section: Discussionmentioning

confidence: 99%

“…5 Eosinophilic fasciitis rarely occurs in childhood, 6 with only approximately 32 cases of pediatric EF published up to 2008. 9 The childhood form of EF is similar to that in adults. 10 According to Grisanti et al, 11 the clinical manifestations, laboratory parameters, and response to therapy for pediatric EF are generally indistinguishable from the adult cases.…”

mentioning

confidence: 82%

Eosinophilic Fasciitis in a Pediatric Patient

Loupasakis¹,

Derk²

2010

JCR: Journal of Clinical Rheumatology

View full text Add to dashboard Cite

We report the case of a pediatric patient with eosinophilic fasciitis, who was successfully treated with early high dose corticosteroids and subsequent use of mycophenolate mofetil. We believe that the early institution of corticosteroids helped to suppress the early inflammatory part of the disease and the subsequent use of mycophenolate mofetil maintained this and may have also helped prevent fibrotic skin changes.

show abstract

“…[75] Pompholyx Low dose MTX can be used for the treatment of severe and recalcitrant dyshidrotic eczema [76,77] but there is no published data in the pediatric population.…”

Section: Eosinophilic Fasciitismentioning

confidence: 99%